Showing 1 - 4 results of 4 for search 'Hidde Eijkelenkamp', query time: 0.02s
Refine Results
-
1
-
2
Precision radiotherapy using MR-linac for pancreatic neuroendocrine tumors in MEN1 patients (PRIME): a protocol for a phase I-II trial, and systematic review on available evidence... by Eline N. M. van Vliembergen, Eline N. M. van Vliembergen, Hidde Eijkelenkamp, Gerlof D. Valk, Menno R. Vriens, Gert J. Meijer, Martijn P. W. Intven, Joanne M. de Laat, Joanne M. de Laat
Published 2023-05-01
Article -
3
Clinical outcomes after online adaptive MR-guided stereotactic body radiotherapy for pancreatic tumors on a 1.5 T MR-linac by Hidde Eijkelenkamp, Guus Grimbergen, Lois A. Daamen, Hanne D. Heerkens, Hanne D. Heerkens, Saskia van de Ven, Stella Mook, Gert J. Meijer, Izaak Q. Molenaar, Hjalmar C. van Santvoort, Eric Paulson, Beth Ann Erickson, Helena M. Verkooijen, William Adrian Hall, Martijn P. W. Intven
Published 2023-10-01
Article -
4
Towards Response ADAptive Radiotherapy for organ preservation for intermediate-risk rectal cancer (preRADAR): protocol of a phase I dose-escalation trial by Miangela M Lacle, Sjoerd G Elias, Leon M G Moons, Helena M Verkooijen, Manon N G J A Braat, Myriam Chalabi, Corrie A M Marijnen, Femke P Peters, Brechtje A Grotenhuis, Miriam Koopman, Petur Snaebjornsson, Esther Consten, Wilhelmina M U van Grevenstein, Maaike E Verweij, Max D Tanaka, Chavelli M Kensen, Uulke A van der Heide, Tomas Janssen, Tineke Vijlbrief, Monique Maas, Inge L Huibregtse, Remond Fijneman, Apollo Pronk, Anke B Smits, Joost T Heikens, Hidde Eijkelenkamp, Maartje M C Schoenmakers, Gert J Meijer, Martijn Intven
Published 2023-06-01
Article